aser Varicose Vein Surgery associated with Foam treatment of Varicose Veins

Phase 3

• Conditions: Great saphenous vein insufficiency; Varicose veins; C14.907.927

• Registration Number: RBR-4xbmk94
• Lead Sponsor: niversidade Federal de Santa Catarina

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-10-07
• Study Completion: 2021-10-31
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients older thant 18 years old, with varicose veins in the lower limbs with total insufficiency of the great saphenous vein
and who agree to participate in the study and sign the consent form.

Exclusion Criteria

Patients with previous deep vein thrombosis, patients with reflux in the deep venous system, patients with small saphenous vein insufficiency, patients with thrombophilia or other coagulation disorders, patients with allergies to Polidocanol or Lidocaine, patients with active cancer, patients with of severe peripheral arterial disease, pregnant or lactating patients, patients with severe diseases and patients with symptomatic patent foramen ovale

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is expected to find a similar rate of great saphenous vein occlusion between the two different methods, one year after the procedure, performed through the echo-color-Doppler exam, based on the finding of a variation of less than 5% in the measurements after the intervention.

Secondary Outcome Measures

Name	Time	Method
To assess the specific quality of life for venous disease one year after the procedure by applying the Aberdeen questionnaire;To verify the complications rate between the different groups within a year interval